Subscribe to Supplier

Subscribe to Supplier

.
enGenes presenting X-cite Continuous Manufacturing technology to EFIB 2021 Vienna

enGenes Biotech GmbH News Releases

Find the latest News from enGenes Biotech GmbH

Page 1 of 2
enGenes presenting X-cite Continuous Manufacturing technology to EFIB 2021 Vienna
enGenes presenting X-cite Continuous Manufacturing technology to EFIB 2021 Vienna Learn More >
enGenes X-press achieves high yield SARS CoV-2 nucleocapsid protein expression
enGenes X-press achieves high yield SARS CoV-2 nucleocapsid protein expression Learn More >
Studies confirm usefulness of enGenes Biotech’s high quality SARS CoV-2 antigens
Studies confirm usefulness of enGenes Biotech’s high quality SARS CoV-2 antigens Learn More >
New study shows ecological benefits for enGenes Biotech X-press technology
New study shows ecological benefits for enGenes Biotech X-press technology Learn More >
New enGenes Biotech study demonstrates benefits of new X-press host strain for recombinant protein production
New enGenes Biotech study demonstrates benefits of new X-press host strain for recombinant protein production Learn More >
enGenes Biotech and TU Wien joint study demonstrates manufacturing benefits of extracellular secretion using X-press technology
enGenes Biotech and TU Wien joint study demonstrates manufacturing benefits of extracellular secretion using X-press technology Learn More >
enGenes Biotech brings latest downstream production solutions and COVID-19 antigens to BIO-Europe Digital
enGenes Biotech brings latest downstream production solutions and COVID-19 antigens to BIO-Europe Digital Learn More >
Research study on phage-inspired growth decoupled recombinant protein production in Escherichia coli
Research study on phage-inspired growth decoupled recombinant protein production in Escherichia coli Learn More >
enGenes Biotech supports Vienna-based initiative to establish serology test for Covid-19
enGenes Biotech supports Vienna-based initiative to establish serology test for Covid-19 Learn More >
enGenes Biotech reaches proof-of-concept for XPAND bioreactor scale non-canonical amino acid incorporation process
enGenes Biotech reaches proof-of-concept for XPAND bioreactor scale non-canonical amino acid incorporation process Learn More >
enGenes brings enhanced protein yield opportunities to EFIB Brussels
enGenes brings enhanced protein yield opportunities to EFIB Brussels Learn More >
enGenes participates in SynBIOcarb initiative
enGenes participates in SynBIOcarb initiative Learn More >
Page 1 of 2